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Abstract
Background: Aspirin-intolerant asthma (AIA), which is caused by non-steroidal anti-inflammatory drugs (NSAIDs) such 
as aspirin, causes lung inflammation and reversal bronchi reduction, leading to difficulty in breathing. Aspirin is known 
to affect various parts inside human body, ranging from lung to spermatogenesis. FSIP1, also known as HDS10, is a 
recently discovered gene that encodes fibrous sheath interacting protein 1, and is regulated by amyloid beta precursor 
protein (APP). Recently, it has been reported that a peptide derived from APP is cleaved by α disintegrin and 
metalloproteinase 33 (ADAM33), which is an asthma susceptibility gene. It has also been known that the FSIP1 gene is 
expressed in airway epithelium.
Objectives: Aim of this study is to find out whether FSIP1 polymorphisms affect the onset of AIA in Korean population, 
since it is known that AIA is genetically affected by various genes.
Methods: We conducted association study between 66 single nucleotide polymorphisms (SNPs) of the FSIP1 gene and 
AIA in total of 592 Korean subjects including 163 AIA and 429 aspirin-tolerant asthma (ATA) patients. Associations 
between polymorphisms of FSIP1 and AIA were analyzed with sex, smoking status, atopy, and body mass index (BMI) as 
covariates.
Results: Initially, 18 SNPs and 4 haplotypes showed associations with AIA. However, after correcting the data for 
multiple testing, only one SNP showed an association with AIA (corrected P-value = 0.03, OR = 1.63, 95% CI = 1.23-2.16), 
showing increased susceptibility to AIA compared with that of ATA cases. Our findings suggest that FSIP1 gene might 
be a susceptibility gene for aspirin intolerance in asthmatics.
Conclusion: Although our findings did not suggest that SNPs of FSIP1 had an effect on the reversibility of lung function 
abnormalities in AIA patients, they did show significant evidence of association between the variants in FSIP1 and AIA 
occurrence among asthmatics in a Korean population.
Background
Asthma is a disease that affects a large number of people
globally, which is estimated to be about 300 million
worldwide [1] and about 3 million asthma patients in
South Korea. The disease is defined by the lung inflam-
mation and difficulty of breathing when the suspect is
under the influence of various factors that trigger the
asthma reaction. Among these factors, non-steroidal
anti-inflammatory drugs such as aspirin are known to
cause aspirin-intolerant asthma. The AIA was first
described in 1922 [2,3], and its most noticeable symp-
toms include aspirin sensitivity, bronchial asthma, and
chronic rhinosinusitis with nasal polyposis [4-6]. When
non-steroidal anti-inflammatory drugs such as aspirin
are ingested, the drugs cause bronchoconstriction in the
patients. Aspirin, also known as acetylsalicylic acid, is pri-
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marily used as pain and fever reliever, and as an anti-
inflammatory medication. One function of aspirin is
decrease of prostaglandin production, with the most sig-
nificant effect of decrease in the prostaglandin on the
alleviation of inflammation and pain.
Recently, there have been several reports that found the
relation between AIA and genetic polymorphisms, such
as Adenosine A1 receptor (ADORA1) polymorphisms
1405C > T and A102A [5]; several polymorphisms in
prostaglandin receptors and thromboxane receptor [7];
Interleukin 10 (IL10) polymorphism -1082 A > G [8];
cysteinyl leukotriene receptor 1 (CYSLTR1) promoter
polymorphism -634C > T [6]; angiotensin I converting
enzyme (ACE) polymorphisms -262 A > T and -115 T > C
[9]; and Fc Fragment of IgE (FCER1G) polymorphism -
237A > G [10]. These results suggest that other genes or
complex signal pathways might be related to the develop-
ment of aspirin hypersensitivity in asthmatics.
Fibrous sheath interacting protein 1 gene (FSIP1), also
known as HSD10, is a recently discovered gene that was
first described in 2003 [11]. With its primary function on
protein binding, the FSIP1 gene is expressed in airway
epithelium (GSE4498 and GDS2486, GEO database) [12].
It has been reported that FSIP1 is regulated by amyloid
beta (Aβ) precursor protein (APP) [13]. APP is an integral
membrane protein expressed in many tissues, and partic-
ularly, in the synapses of neurons. There has been a
report that APP is cleaved by α disintegrin and metallo-
proteinase 33 (ADAM33), which is an asthma susceptibil-
ity gene [14,15]. Based on these findings, we
hypothesized  FSIP1  g e n e  c o u l d  h a v e  a n  e f f e c t  o n  t h e
mechanism of aspirin on the various levels, including
onset of AIA, and conducted association analyses of
FSIP1  gene polymorphisms between AIA and ATA
patients. We also conducted association analyses
between SNPs of FSIP1 and fall rate of FEV1 by aspirin
provocation.
Methods
Study Subjects
This study was conducted in compliance with the Global
Initiative for Asthma (GINA) Global strategy for asthma
management and prevention Study. A total of 592 sub-
jects were recruited from the Asthma Genome Research
Center comprising hospitals of Soonchunhyang Seoul
and Bucheon Hospital, Chungnam, Chungbuk, and Seoul
national university in Korea. All subjects provided
informed consent, and the protocols were approved by
the Institutional Review Board of each hospital. Each
patient showed airway reversibility such as the inhalant
bronchodilator-induced improvement with over 15% of
forced expiratory volume in 1 s (FEV1) and/or the airway
hyperresponsiveness to the provocative concentration of
P20 methacholine [16]. Aspirin challenge was performed
as previously described [17]. Subjects showing a fall rate
of FEV1 less than 15% without skin manifestations were
included in ATA group. The clinical profiles of subjects
are listed in Table 1.
All patients had a history of dyspnea and wheezing dur-
ing the previous 12 months, plus one of the following: 1)
>15% increase in FEV1 or >12% increase plus 200 mL fol-
lowing inhalation of a short-acting bronchodilator, 2) <10
mg/mL PC20 methacholine, and 3) >20% increase in
FEV1 following 2 weeks of treatment with inhaled ste-
roids and long-acting bronchodilators. Twenty-four com-
mon inhalant allergens were used for a skin prick test [9].
Total IgE was measured by the CAP system (Pharmacia
Diagnostics, Uppsala, Sweden). Atopy was defined as
having a wheal reaction equal to or greater than hista-
mine or 3 mm in diameter. The asthmatic patients had
experienced no exacerbation of asthma and respiratory
tract infection in the 6 weeks preceding oral aspirin chal-
lenge (OAC). OAC was performed with increasing doses
of aspirin using methods slightly modified from those
described previously [9,18]. Changes in FEV1 were fol-
lowed for 5 hours after the last aspirin challenge dose.
Aspirin-induced bronchospasms, as reflected by rate (%)
of FEV1  decline, were calculated as the pre-challenge
FEV1 minus the post-challenge FEV1 divided by the pre-
challenge FEV1. OAC reactions were categorized into 2
groups as follows: 15% or greater decreases in FEV1 with
naso-ocular or cutaneous reactions (aspirin intolerant
asthma: AIA), and less than 15% decreases in FEV1 with-
out naso-ocular or cutaneous reactions (aspirin tolerant
asthma: ATA).
SNP selection and genotyping
We selected candidate SNPs showing polymorphic in the
National Center for Biotechnology Information (build
36), and then genotyped in 163 AIA and 429 ATA sub-
jects. Genotyping was performed at a multiplex level of
using the Illumina Golden Gate genotyping system [19]
and data quality was assessed by duplicate DNAs (n = 10).
The genotype quality score for retaining data was set to
0.25. SNPs that could not satisfy the following criteria
were excluded: (i) a minimum call rate of 90%; (ii) no
duplicate error; (iii) Hardy-Weinberg equilibrium greater
than P > 0.001. A total of 66 SNPs from FSIP1 were suc-
cessfully genotyped.
Statistics
We examined Lewontin's D' (|D'|) and the linkage dis-
equilibrium (LD) coefficient r2 between all pairs of bial-
lelic loci. Linkage disequilibrium was inferred using the
algorithm developed by the Broad Institute (using the
program Haploview) [20]. Haplotypes were first esti-
mated by using PHASE software [21], and then computedKim et al. BMC Pulmonary Medicine 2010, 10:34
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by logistic analyses using the Statistical Analysis System
(SAS). Subjects harboring missing genotypes were omit-
ted in the analysis of individual single-nucleotide poly-
morphisms and haplotypes. The genotyping success rate
was >99%, so it is unlikely that omitting a small number
of individuals introduced any bias in the analysis. The
genotype and haplotype association with AIA were ana-
lyzed using logistic models with age (continuous value),
gender (male = 0, female = 1), smoking status (non-
smoker = 0, ex-smoker = 1, smoker = 2), atopy (absence =
0, presence = 1), and BMI as covariates. Significant asso-
ciations are shown in bold face (P < 0.05). The common
alleles were used as the referent genotype to the heterozy-
gote and homozygote of the minor allele in referent anal-
ysis. The association analyses of differences in the fall
rates in FEV1 following aspirin challenge with the geno-
types and haplotypes were examined by regression analy-
sis using SAS. The data were managed and analyzed using
SAS. The effective numbers of independent marker loci
in each genes were calculated to correct for multiple test-
ing using the software SNPSpD [22], which is based on
the spectral decomposition (SpD) of matrices of pair-wise
LD between SNPs [22].
Results
Subject Characteristics
A total of 592 asthma patients were recruited for this
study, and there were 163 AIA patients and 429 ATA
cases (Table 1). First of all, the fall rate by aspirin provo-
cation in AIA patients showed significantly higher fall
rate (24.63%) than ATA cases (3.54%) (P < 0.0001, Table
1). Among the total subjects, 27.70% were current smok-
ers, with more smokers within ATA patients (30.07%)
than AIA patients (21.47%). Also, the positive skin test
rate of AIA was smaller than that of ATA patients (52.76
and 57.81, respectively).
SNP Analyses
Figure 1 shows the physical map of FSIP1, which contains
66 SNPs of the FSIP1 gene along with positions at exons
and introns. Most of the variants were located in intronic
regions (Additional File 1). In case of SNPs in coding
region, two nonsynonymous SNPs, rs10152640  and
rs16969386, were located in exon11 region, and they also
caused amino acid change, with the former causing
cysteine to arginine amino acid change at position 402,
while the latter caused glycine to alanine amino acid
change at position 528.
I n  l o g i s t i c  a n a l y s i s  f o r  as s oc i a t i o n s  be t w ee n  S N P s  o f
FSIP1 and AIA in a Korean population with adjustment
for age, sex, smoking status, atopy and BMI, there was 18
SNPs showing initial significant associations and one
SNP showing significant association after correction
(rs7179742, P = 0.0007, Pcor. = 0.03, OR = 1.63, 95% CI =
1.23-2.16). Detailed analyses of rs7179742, along with
other SNPs in the same haplotype block (FSIP1_BL1), are
shown in Table 2. Although rs7179742 was the only SNP
with significant relation after correction for multiple test-
ing, SNPs in FSIP1_BL1 had considerably significant P-
values before correction for multiple testing. Further-
Table 1: Clinical profiles of AIA patients and ATA cases.
Clinical profile Asthmatics (all subject) AIA ATA
N 592 163 429
Age of first medical examination (mean (range)) 46.15 (15.40-77.88) 43.13 (17.22-72.73) 47.30 (15.40-77.88)
Height (cm) 160.78 ± 8.63 161.72 ± 8.69 160.42 ± 8.39
Weight (kg) 62.81 ± 10.84 61.25 ± 10.38 63.40 ± 10.97
Fall rate (%) 9.27 ± 13.24 24.63 ± 16.11 3.54 ± 4.85
Blood eosinophil (%) 6.01 ± 5.73 5.96 ± 5.21 6.03 ± 5.92
FVC %, predicted 88.54 ± 14.08 90.35 ± 14.04 87.85 ± 14.05
FEV1 %, predicted 90.54 ± 16.97 87.58 ± 16.94 91.66 ± 16.87
PC20, methacholine (mg/ml) 6.43 ± 8.67 5.02 ± 7.83 6.91 ± 8.90
Total IgE (IU/ml)* 156 (62, 394) 164 (78, 357) 154 (53, 416)
Sex (male/female) 206/386 59/104 147/282
Current Smoker (%) 27.70 21.47 30.07
Positive rate of skin test (%) 56.42 52.76 57.81
Fall rate refers to the decline of FEV1% by aspirin provocation.
*Total IgE value is shown as median (25% interquartile interval, 75% interquartile interval).
AIA, aspirin-intolerant asthma; ATA, aspirin-tolerant asthma; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.Kim et al. BMC Pulmonary Medicine 2010, 10:34
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more, SNPs in FSIP1_BL1  including  rs7179742  were
observed to have an effect on the increased fall rate of
FEV1 by aspirin provocation (Table 3).
Logarithms for P-values of all SNPs were calculated for
the better representation of the values (Figure 2). Simul-
taneously, negative log of 0.05 and 0.0001, where latter
value equals to 0.05 after correction for multiple testing
(multiple testing correction number = 49.39), show the
lines for significant association. In particular, SNPs with
its value exceeding lower line (negative log of 0.05) would
have initial association with AIA, and if it exceeds upper
line (negative log of 0.0001), it would still have significant
association after correction for multiple testing. As
shown in Figure 2, there were 18 SNPs out of 66 that
showed initial significant association with AIA. 12 SNPs
out of the 18 showed association with the susceptibility to
the risk of AIA, furthermore, rs7179742 had significantly
higher MAF for AIA than that of ATA, showing increased
susceptibility of AIA (MAF = 0.358 and 0.262, respec-
tively). On the other hand, six SNPs out of the 18 showed
lower minor allele frequencies in AIA patients compared
to those of ATA cases.
Haplotypes Analyses
Haplotypes were calculated using PHASE software, and
there were 3 haplotype blocks identified (Figure 3). Inter-
estingly, pair-wise comparisons showed tight LD with
three LD blocks among 66 SNPs of the FSIP1 gene. From
each haplotype blocks, a total of 13 haplotypes with fre-
quencies higher than 0.05 are listed (Figure 3A). Among
them, 4 haplotypes showed initial association with AIA,
as detailed analyses of the haplotypes are listed in Table 4.
Three haplotypes, FSIP1_BL1_ht4  (P  = 0.03),
FSIP1_BL2_ht4 (P = 0.02), FSIP1_BL3_ht3 (P = 0.04) and
FSIP1_BL3_ht4 (P = 0.01), were frequent in AIA patients,
whereas  FSIP1_BL3_ht3  revealed a lower frequency in
AIA compared to that of ATA cases, respectively. How-
ever, their signals disappeared after the correction for
multiple testing.
Discussion
Most of the SNPs were located in intronic region, but two
SNPs, rs10152640 and rs16969386, were located in exon
region. They also caused amino acid change, as
rs10152640  caused cysteine to arginine amino acid
change at position 402 and rs16969386 caused glycine to
alanine amino acid change at position 528. Nonsynony-
mous amino acid changes have significant effect on the
Figure 1 A physical map of FSIP1 on chromosome 15q14. Exons, introns, UTR, and SNPs are shown. Coding exons are marked by shaded blocks; 
UTRs by white blocks. SNPs with complete LD are represented by r2 = 1.Kim et al. BMC Pulmonary Medicine 2010, 10:34
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expression and function of the protein [23,24]. In particu-
lar, the hydrophobicity change from cysteine to arginine
(2.5 and -4.5 of hydrophobicity, respectively) on the
rs10152640  could induce a critical conformational or
functional change of the protein. However, when the
association between two nonsynonymous SNPs of FSIP1
and the fall rate of FEV1 by aspirin provocation was ana-
lyzed, no significant association was found (data not
shown), indicating that these nonsynonymous variants
could not have a direct effect on the activities of FSIP1
protein.
From the association analyses of FSIP1 gene with AIA,
we initially found 18 polymorphisms that showed associ-
ation. In addition, significant associations of several SNPs
in FSIP1_BL1 and FSIP1_BL2 with the fall rate of FEV1 by
aspirin provocation were found (data for FSIP1_BL2 not
shown). However, after multiple testing correction, only
rs7179742 (P = 0.0007, Pcor. = 0.03, OR = 1.63, 95% CI =
1.23-2.16) showed increased susceptibility of AIA. The
possible susceptibility of rs7179742  to AIA was rein-
forced by the significant association of this variant with
the increased fall rate of FEV1 by aspirin provocation (P =
0.01 in co-dominant model, Table 3). Although this SNP
is located in the intronic region of the gene, intronic
region can still affect overall transcription in different
ways. It was reported that introns can affect transcription
efficiency [25], and another study demonstrated that vari-
ations in intronic region can lead to splicing abnormali-
ties, which in turn may lead to human diseases [26]. It
was also reported recently that a SNP located in intronic
region showed an association with asthma [27]. On the
other hand, in additional analysis of LD near FSIP1 in
Asian populations (Chinese and Japanese) from the Inter-
national HapMap Project http://hapmap.ncbi.nlm.
nih.gov/, the FSIP1 gene is in LD with the thrombospon-
din-1  (THBS1 or TSP-1) gene (Additional File 2). The
THBS1 gene has been implicated in the network underly-
ing the pulmonary response to oxidative stress in asthma
[28]. More interestingly, aspirin, as an inhibitor of
THBS1, has recently shown to lead to reduction in
THBS1 levels [29]. This suggests that FSIP1 might have
an effect on aspirin hypersensitivity in asthma, with rela-
tion to the nearby potential gene of THBS1.
The  FSIP1  gene has been discovered very recently.
FSIP1 is regulated by APP, an integral member protein
that is found in many tissues. APP, in turn, is cleaved by
an asthma susceptible gene called ADAM33  [30].
ADAM33  polymorphisms have been associated with
asthma risk in various populations, including Korea [31],
Thai, Han Chinese and Japanese [32-34], who are closely
related with Korean population, especially Han Chinese
and Japanese. The ADAM33 polymorphisms have also
Table 2: Logistic and statistical analyses of FSIP1 SNPs in haplotype block 1.
rs# Position MAF Heterozygosity HWE OR(95%CI) PP c o r .
AIA ATA Total
rs1602543 Intron2 0.199 0.235 0.226 0.350 0.997 0.81 (0.59-1.11) 0.19 1.00
rs7179742 Intron2 0.358 0.262 0.287 0.409 0.765 1.63 (1.23-2.16) 0.0007 0.03
rs1021411 Intron3 0.292 0.227 0.242 0.367 0.885 1.47 (1.09-1.98) 0.01 0.55
rs1021410 Intron3 0.352 0.262 0.284 0.407 0.751 1.60 (1.20-2.13) 0.001 0.06
rs12440567 Intron3 0.325 0.240 0.261 0.386 0.788 1.58 (1.18-2.10) 0.002 0.09
rs2576932 Intron3 0.443 0.508 0.490 0.500 0.786 0.75 (0.58-0.98) 0.03 1.00
rs10520151 Intron5 0.027 0.023 0.024 0.047 0.274 1.17 (0.53-2.59) 0.70 1.00
rs16969802 Intron5 0.322 0.239 0.260 0.384 0.705 1.56 (1.17-2.08) 0.002 0.11
rs12911842 Intron5 0.211 0.260 0.242 0.367 0.467 0.73 (0.54-0.99) 0.04 1.00
rs7179417 Intron5 0.446 0.509 0.492 0.500 0.815 0.76 (0.59-0.98) 0.04 1.00
rs4115216 Intron5 0.446 0.510 0.493 0.500 0.877 0.76 (0.58-0.98) 0.03 1.00
rs8033957 Intron5 0.527 0.468 0.485 0.500 0.511 1.28 (1.00-1.66) 0.05 1.00
rs6492915 Intron5 0.527 0.468 0.485 0.500 0.511 1.28 (1.00-1.66) 0.05 1.00
rs8031241 Intron5 0.452 0.513 0.497 0.500 0.905 0.76 (0.59-0.99) 0.04 1.00
rs1906164 Intron6 0.232 0.249 0.247 0.372 0.852 0.91 (0.67-1.23) 0.53 1.00
MAF, minor allele frequency; AIA, aspirin-intolerant asthma; ATA, aspirin-tolerant asthma; HWE, Hardy-Weinberg Equilibrium;
OR, odds ratio; CI, confidence interval; Pcor., corrected P-value.Kim et al. BMC Pulmonary Medicine 2010, 10:34
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Page 6 of 9
been related with asthma risk of smoking population
[35,36]. These results suggest that the FSIP1 gene could
have a correlation with APP and/or ADAM33 in develop-
ment of asthma. In addition, the fact that aspirin affects
wide range of human body, from lung to blood clotting to
spermatogenesis, has to be considered. Naturally, the
mechanism and pathways of aspirin is intricate and com-
plicated.
One of limitation of our study is the small number of
AIA patient, which might result in decreasing the statisti-
cal power of this study. However, considering the rare-
ness of AIA condition, our results could provide
supporting information, with further needs of replication
in large number of subjects. Taken together, even though
current knowledge of FSIP1 gene implicates that it only
affects a small part out of aspirin pathways, our findings
suggest a new relation between FSIP1 and aspirin hyper-
sensitivity that explains the association found in this
study.
Conclusions
In summary, we found 18 SNPs and 4 haplotypes of FSIP1
showing associations with AIA initially, and after multi-
ple testing correction, one SNP, rs7179742 showed signif-
icant association with AIA. Although the relation
between the FSIP1 gene and AIA is not yet clearly under-
stood, our findings suggest that FSIP1-related regulations
of APP and ADAM33 may play a role for the development
of aspirin hypersensitivity in asthmatics, along with the
fact that FSIP1 is expressed in airway epithelium. Future
researches should concentrate on this part to discover
more about the role of FSIP1 gene and also the relation
between the gene and various diseases including AIA.
Table 3: Association analysis between SNPs of FSIP1 gene and the fall of FEV1 by aspirin provocation.
rs# C/C C/R R/R P*
n Fall rate n Fall rate n Fall rate
rs1602543 356 9.74 ± 13.12 205 8.25 ± 13.03 31 9.88 ± 15.55 0.43
rs7179742 300 8.29 ± 12.05 241 9.49 ± 14.15 51 13.54 ± 14.55 0.01
rs1021411 335 8.84 ± 12.89 223 9.58 ± 13.87 34 10.88 ± 12.14 0.26
rs1021410 299 8.30 ± 12.03 245 9.56 ± 14.13 48 13.38 ± 14.86 0.01
rs12440567 322 8.36 ± 12.33 227 9.81 ± 14.15 43 12.76 ± 14.11 0.02
rs2576932 157 11.33 ± 15.8 290 8.34 ± 11.80 144 8.76 ± 12.69 0.06
rs10520151 564 9.15 ± 13.02 27 0.71 ± 17.32 1 13.8 0.50
rs16969802 324 8.38 ± 12.32 225 9.80 ± 14.18 43 12.68 ± 14.14 0.02
rs12911842 341 9.57 ± 13.93 210 9.30 ± 12.54 41 6.09 ± 9.94 0.14
rs7179417 156 11.40 ± 15.8 291 8.25 ± 11.78 145 8.87 ± 12.64 0.06
rs4115216 155 11.46 ± 15.8 292 8.23 ± 11.77 145 8.87 ± 12.64 0.06
rs8033957 162 9.08 ± 13.21 284 8.22 ± 11.59 145 11.41 ± 15.8 0.10
rs6492915 162 9.08 ± 13.21 284 8.22 ± 11.59 145 11.41 ± 15.8 0.10
rs8031241 153 11.52 ± 15.9 291 8.20 ± 11.76 147 8.91 ± 12.62 0.06
rs1906164 339 9.25 ± 12.60 216 9.21 ± 13.94 37 9.24 ± 14.74 0.98
*P-values of regression analysis represent the co-dominant model controlling sex, smoking status, and atopy as covariates.
C/C, C/R and R/R indicate the homozygote of common allele, and the heterozygote and homozygote of rare allele, respectively.
Fall rate values are mean ± standard deviation.
Figure 2 A graph of negative log of P-values of SNPs. After correc-
tion for multiple testing, all SNPs are calculated for the better represen-
tation of the values. The log = 0.0001 equals to P = 0.05. SNP rs7179742, 
which is the only SNP to have significant P-value after the multiple cor-
rections, is highlighted in black.Kim et al. BMC Pulmonary Medicine 2010, 10:34
http://www.biomedcentral.com/1471-2466/10/34
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Table 4: Logistic and statistical analyses of FSIP1 haplotypes.
Haplotypes MAF Heterozygosity HWE OR (95%CI) PP c o r .
AIA ATA Total
FSIP1-_ BL1_ht1 0.235 0.256 0.254 0.379 0.770 0.91 (0.67-1.23) 0.52 1.00
FSIP1-_BL1_ ht2 0.202 0.241 0.227 0.351 0.683 0.76 (0.55-1.03) 0.08 1.00
FSIP1-_BL1_ ht3 0.187 0.214 0.208 0.330 0.498 0.85 (0.62-1.16) 0.30 1.00
FSIP1-_BL1_ ht4 0.244 0.190 0.202 0.322 0.546 1.42 (1.04-1.94) 0.03 1.00
FSIP1-_BL2_ ht1 0.262 0.302 0.295 0.416 0.614 0.82 (0.62-1.09) 0.18 1.00
FSIP1-_BL2_ ht2 0.199 0.226 0.214 0.336 0.207 0.82 (0.60-1.11) 0.20 1.00
FSIP1-_BL2_ ht3 0.130 0.148 0.146 0.250 0.400 0.88 (0.61-1.27) 0.49 1.00
FSIP1-_BL2_ ht4 0.151 0.098 0.111 0.197 0.908 1.61 (1.10-2.37) 0.02 0.76
FSIP1-_BL2_ ht5 0.123 0.104 0.109 0.195 0.839 1.34 (0.89-2.01) 0.17 1.00
FSIP1-_BL3_ ht1 0.238 0.291 0.283 0.406 0.011 0.78 (0.59-1.04) 0.09 1.00
FSIP1-_BL3_ ht2 0.298 0.269 0.278 0.401 0.600 1.21 (0.91-1.60) 0.19 1.00
FSIP1-_BL3_ ht3 0.157 0.202 0.187 0.304 0.575 0.70 (0.50-0.98) 0.04 1.00
FSIP1-_BL3_ ht4 0.117 0.072 0.085 0.155 0.200 1.76 (1.13-2.74) 0.01 0.66
MAF, minor allele frequency; AIA, aspirin intolerant asthma; ATA, aspirin tolerant asthma; HWE, Hardy-Weinberg equilibrium number; OR, odd 
ratio; CI, confidence interval; Pcor., corrected P-value.
Figure 3 Haplotypes and LDs of FSIP1 gene. (A) Haplotypes of FSIP1 in the Korean population. They are divided into 3 haplotype blocks. Only those 
with frequencies over 0.05 are shown. (B) LD coefficients graphical plot (|D'|) among SNPs based on the genotypes of whole study subjects in this 
study (n = 592).Kim et al. BMC Pulmonary Medicine 2010, 10:34
http://www.biomedcentral.com/1471-2466/10/34
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